MOSS — Moss Genomics Balance Sheet
0.000.00%
- CA$3.46m
- -CA$0.06m
- 45
- 73
- 32
- 49
Annual balance sheet for Moss Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.001 | 0.688 | 0.018 | 0.012 | 1.13 |
| Net Total Receivables | 0.108 | 0.002 | 0.016 | 0.02 | 0.025 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.109 | 0.689 | 0.06 | 0.032 | 1.17 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.112 | 0.067 | 0.041 | 0.021 |
| Total Assets | 0.109 | 0.802 | 0.127 | 0.073 | 1.2 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.12 | 0.14 | 0.051 | 0.099 | 0.259 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.12 | 0.14 | 0.051 | 0.099 | 0.259 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.012 | 0.661 | 0.076 | -0.027 | 0.937 |
| Total Liabilities & Shareholders' Equity | 0.109 | 0.802 | 0.127 | 0.073 | 1.2 |
| Total Common Shares Outstanding |